Industry Updates
Press Releases
M42 Announces New Clinical LLM to Transform the Future of AI in Healthcare
M42, a global tech-enabled healthcare network, has unveiled an impactful advancement in healthcare technology with the launch of Med42, a new open-access Clinical Large Language Model (LLM). The 70 billion parameter, generative artificial intelligence (AI) model is poised to...
Press Releases
Mount Sinai Announces Partnership With the Chiba Institute of Technology in Japan Focusing on Artificial Intelligence to Transform Cardiovascular Research
The Icahn School of Medicine at Mount Sinai announced that it has signed a memorandum of understanding with the Chiba Institute of Technology (CIT) to collaborate on using artificial intelligence (AI) for cardiovascular disease research. The goal is to...
Press Releases
InterSystems Expands Startup Program with Eight New Companies to Accelerate Digital Health Innovation
InterSystems Startup Program now connects a total of 35 startups to the health and care ecosystem
SYDNEY, Australia & SINGAPORE – October 11, 2023 – InterSystems, a creative data technology provider dedicated to helping customers solve the most critical scalability, interoperability and...
Press Releases
Veradigm, On Belay Health Solutions Expand Value-Based Care Solutions to More Primary Care Practices
Veradigm Inc., a leading provider of healthcare data and technology solutions and On Belay Health Solutions, the company on a mission to empower primary care practices to succeed in value-based care, announced today a strategic collaboration to support primary...
Press Releases
AccuLine Announces Know-How License Agreement with Mayo Clinic to Advance Early Detection of Heart Attacks
AccuLine, a digital health startup company, has announced to collaboration with Mayo Clinic through a know-how license agreement for the advancement of CORA, AccuLine's novel solution designed for the early detection of coronary artery disease (CAD). As part of...
Press Releases
Evecxia Therapeutics, Quotient Sciences Complete Clinical Milestone for Depression Treatment
A drug development partnership between Evecxia Therapeutics and Quotient Sciences has resulted in the successful delivery of a Phase 1 clinical testing program for Evecxia’s drug candidate EVX-101, which is in development for major depressive disorder (MDD).
Quotient Sciences’ Translational...
Press Releases
Microsoft and Mercy collaborate to empower clinicians to transform patient care with generative AI
Microsoft Corp. and Mercy are forging a long-term collaboration using generative AI and other digital technologies to give physicians, advance practice providers and nurses more time to care for patients and improve the patient experience. This work represents what’s...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
